I n 2010, the Society of Critical Care Medicine organized a task force to raise awareness of the long-term cognitive, psychological, and physical impairments of survivors of critical illness. Impairments in these 3 domains are collectively known as post-intensive care syndrome (PICS). 1 PICS affects 50% to 70% of intensive care unit (ICU) survivors, and its effects can persist for 5 to 15 years after ICU hospitalization. 2 A major barrier in the detection of PICS is the lack of a single, validated clinical tool to rapidly assess patients for impairments in all 3 domains of the syndrome. 1 The self-report version of the Healthy Aging Brain Care Monitor (HABC-M SR) is a 27-item questionnaire used to evaluate cognitive, functional, and psychological domains 3 (see Figure) . Patients indicate how often they experienced the target symptoms (cognitive, psychological, and functional) in the preceding 2 weeks. The HABC-M SR can be administered face-to-face, via telephone, or via the internet. The instrument has been validated in older patients with normal cognition, mild cognitive impairment, earlystage dementia, and late-life depression. Our aim in this study was to validate face-to-face administration of the HABC-M SR as a rapid assessment tool for PICS.
Methods

Participants and Setting
A total of 261 patients were recruited from July 2011 to May 2017 at the Critical Care Recovery Center (CCRC) at Eskenazi Hospital, Indianapolis, Indiana, one of the first ICU adult survivor clinics in the United States. 4 Eskenazi Hospital provides health care to a racially diverse, underserved population in the Indianapolis metropolitan area. Patients were included in the study if they were 18 years or older, had been admitted to the Eskenazi ICU, had received mechanical ventilation or had been delirious for more than 48 hours, had been recommended for follow-up by a critical care physician, and had a score greater than 17 on the Mini-Mental State Examination (MMSE). 5 Patients were excluded if they were receiving hospice or palliative care services. Patients who did not complete an HABC-M SR (n = 86) or neuropsychological testing (n = 33) also were excluded from the study.
The final sample included a subgroup of 142 patients who completed both the HABC-M SR and the standardized assessments. Standardized assessments were done at the initial visit, and the HABC-M SR was completed in a week or less during the same visit or a subsequent follow-up visit (mean gap, 7.2 days; SD, 10.0 days A major barrier to detection of PICS is the lack of a single, validated clinical tool to rapidly assess patients for cognitive, functional, and psychological impairments.
www.ajcconline.org younger ICU survivors, we decided to switch the cognitive and depression assessments to the RBANS and PHQ-9, respectively. The PSMS and IADL selfratings can be used for all age ranges. Retrospective analysis of deidentified clinical data was approved by the appropriate institutional review board.
HABC-M SR
The HABC-M SR was developed by an interdisciplinary panel of dementia experts and was validated in patients who had a score greater than 17 on the MMSE. 3 The HABC-M SR (Table 1 ) is a 27-item selfadministered tool used to evaluate cognitive, functional, and psychological symptoms. The cognitive subscale consists of 6 questions about memory, orientation, and judgment. The functional subscale consists of 11 questions about IADLs and activities of daily living (ADLs). The psychological subscale consists of 10 questions about symptoms of depression, psychosis, and anxiety. Each question is rated on the basis of the patient's perceived frequency of the symptom during the 2 preceding weeks: 0 = not at all (0-1 day), 1 = several days (2-6 days), 2 = more than half the days (7-11 days), 3 = almost daily (12-14 days). The maximum scores for cognitive, functional, and psychological subscales are 18, 33, and 30, respectively. The maximum total score is 81. Higher numbers for the 3 subscales and the total score correlate with higher severity of symptoms. 
Standardized Assessments of Cognition
All patients completed the MMSE, a 30-point questionnaire used to assess for cognitive impairment. They also completed the Trail Making Test (TMT), which consists of 2 parts to measure processing speed (TMT-A) and executive functioning (TMT-B). 6 The amount of time needed to complete each part is the score. In TMT-A, the participant sequentially connects 25 encircled numbers distributed on a sheet of paper. In TMT-B, the participant connects circles alternating between numbers and letters in ascending order (eg, 1, A, 2, B, 3, C). Patients then completed either the RBANS or the CERAD-NB. The RBANS is a neuropsychological screening tool validated in patients with a wide range of neuropsychiatric disorders. 7, 8 It yields 5 index scores (attention, language, visuospatial/constructional abilities, immediate memory, delayed memory) and a total scale score (40-160 points). The CERAD-NB is a standardized test battery designed to detect cognitive deficits in patients with Alzheimer dementia. 9 It consists of 8 subtests (verbal fluency, Boston naming, MMSE, word list learning, constructional praxis, word list recall, word list recognition, and constructional praxis recall) used to measure general cognition, semantic fluency, graphomotor construction ability, confrontation naming, and verbal learning and memory.
Standardized Assessments of Psychological Symptoms
All patients completed either the GDS-30 or the PHQ-9 to assess depressive symptoms. The GDS-30 is a 30-item, self-report, yes-no instrument used to measure depression in elderly persons. 10 The PHQ-9 is a self-administered 9-question scale used to rate the frequency of depressive symptoms on a scale of 0 to 3 (0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly every day) during the preceding 2 weeks. 11 A subset of patients also completed the PTSS-10, a 10 item self-report used to screen for posttraumatic stress disorder, with a total severity score of 10 to 70. The items are based on the Diagnosis and Statistical Manual of Mental Disorders (Third Edition) criteria for posttraumatic stress disorder. The PTSS-10 has since been validated in patients with acute respiratory distress syndrome after ICU treatment by using a structured clinical interview based on criteria of the Diagnosis and Statistical Manual of Mental Disorders (Fourth Edition).
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Standardized Assessments of Physical Functioning
Patients or their informal caregivers completed the PSMS, a 6-item questionnaire used to assess a patient's ability to complete ADLs. 13 Each patient's level of functioning for IADLs was also assessed by using a modified version of the Lawton IADL scale 13 ; participants were asked to rate, on a 3-point Likert scale (1 = completely independent to 3 = completely dependent), their ability to perform 7 IADLs (using the telephone, traveling, shopping, preparing meals, doing housework, medication management, and finances).
Data Collection
At the initial visit, the critical care physician completed a history and interview with both the patient and the patient's informal caregiver (if one was available) and performed a full physical examination, including vital signs and a neurological examination. A health care professional or psychometrist administered the HABC-M SR and the standardized assessments of cognition, psychological symptoms, and functional symptoms as described earlier. Medical history and medication lists were collected from patients, informal caregivers, and electronic medical records.
Statistical Analysis
Internal consistency of the scale items was assessed by using Cronbach . Convergent-divergent validity was assessed by performing 2 separate analyses. First, we examined the relationship between the HABC-M SR scales and standardized cognitive, psychological, and functional scales. We expected that the individual scales from the HABC-M SR would correlate highest with the external scales that belonged to the same domain (eg, the HABC-M SR psychological scale would correlate with the GDS-30, PHQ-9, and PTSS-10). Then we used generalized linear models to test whether this association remained significant after we made adjustments for age, sex, and education. We then compared the results for the HABC-M SR from the CCRC cohort with the results of the group used in the original validation study for the HABC-M SR. Patients in the original validation study for the HABC-M SR were recruited if they had had at least 1 visit to primary care during the period from January 1, 2008, to April 1, 2011; were 65 years or older; and had either a diagnosis of cognitive impairment or had received at least 1 prescription of a cholinesterase inhibitor or memantine or had any International Classification of Diseases, Ninth Revision, code indicating depression or had received at least 1 prescription of a selective serotonin reuptake drug. We used the Fisher exact test to test for differences in percentage of patients with the lowest Patients seen in the CCRC were more likely than primary care patients were to report cognitive, functional, or psychological symptoms.
possible score on each scale and the Mann-Whitney test to detect differences in scale scores across the CCRC and primary care populations. All statistical analyses were performed by using SAS 9.4 software (SAS Institute Inc). Table 2 gives characteristics of the 142 patients with PICS. The mean age was 52.3 (SD, 13.0) years, and less than half (47.9%) were female. The cohort reflected the diversity of the Indianapolis metropolitan area. Nearly half were African American (46%), and the mean years of education was 11.8 (SD, 2.3). The most common comorbid conditions were tobacco use disorder (78%), hypertension (70%), chronic obstructive pulmonary disease or other lung disease (46%), and depression (46%). The mean length of ICU stay was 12.1 days, and the mean length of hospital stay was 17.1 days. A total of 45.7% of the patients had an episode of ICU delirium. Most patients (94%) required ventilator support during their ICU stay. Table 3 gives the internal-consistency, reliability, and score distributions of the HABC-M SR. The internal consistency of the HABC-M SR scales was good to excellent (Cronbach , 0.83-0.92). All the subscale and total scores were positively distributed but still covered a wide range of possible answers. The interscale correlation between all of the subscales was moderate (0.610-0.703; see Table 1 ), but indicated that the subscales were distinct. Table 4 provides information on the construct validity of the subscale and total scores of the HABC-M SR. The psychological subscale had the strongest correlations with the standardized measures of psychological symptoms, PHQ-9 (Spearman correlation coefficient, 0.73; n = 67), GDS-30 (0.74; n = 56), and PTSS-10 (0.68; n = 59). The cognitive subscale strongly correlated with only the delayed memory measure of the CERAD-NB (-0.51; n = 56), but did not correlate with any of the measures on the RBANS (n = 76). The functional subscale correlated with the PSMS (-0.26). All these relationships remained significant after adjustments were made for age, sex, and education. Table 5 compares the subscale and total HABC-M SR scores of CCRC patients with those of primary 
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Initial CCRC visit information
Time between initial visit in CCRC and discharge from the hospital (days) Table 3 Internal consistency, reliability, and score distributions for Healthy Aging Brain Center Monitor Self-report care patients (n = 291; mean age, 72.7 years; SD, 6.7 years). The CCRC patients had significantly worse scores for all subscales and the total scale on HABC-M SR. The mean total HABC-M SR score for CCRC patients was nearly double the total score for the primary care patients. These relationships remained significant after adjustments for age and sex. Patients seen in primary care were more likely to report no cognitive, psychological, or functional symptoms than were the CCRC patients (Table 6) .
Discussion
Although epidemiological studies suggest a fairly high prevalence of PICS in patients treated in an ICU, this syndrome remains underrecognized. 1, 2 A major barrier to the recognition of PICS is that it www.ajcconline.org
External scales
The HABC-M SR has potential as a screening tool for rapidly assessing the wide range of symptoms experienced by patients with PICS.
affects multiple domains (physical, psychological, cognition). In an era of subspecialized care, the full spectrum of PICS symptoms may not be detected after the hospital stay. Therefore, a clinical tool that can be used to rapidly assess all these domains is much needed. Our findings suggest that the HABC-M SR may be such a clinical tool. The HABC-M SR psychological and functional subscales were reliable tools for measuring the severity of PICS symptoms. Although the HABC-M cognitive scale had low correlations with the cognitive performance measures, the highest correlation was with the CERAD Delayed Memory Scale, which is the area most related conceptually to the HABC-M SR cognitive scale. This finding suggests that the cognitive subscale in PICS may have limited validity. Despite this limitation of the HABC-M SR, patients seen in the CCRC still reported higher severity of cognitive, psychological, and functional symptoms than did primary care patients. Although the PICS patients in our sample were much younger than the original targeted population for the HABC-M SR, studies have suggested that despite their chronological age, younger ICU survivors may be experiencing the effects of aging similar to the effects apparent in older patients, including marked cognitive deficits. Therefore, clinicians may consider more detailed neuropsychological testing for ICU survivors who report cognitive symptoms. However, normal scores on cognitive subscales should not deter further evaluation if clinicians have concerns about a patient's cognition based on the patient's history and examination.
Most important, our findings lay the groundwork for future development of self-report cognitive scales for PICS, similar to the scales being developed and studied for Alzheimer disease. Although neuropsychological assessment (an interview with a reliable informant and use of a full testing battery) remains the gold standard for a workup for a patient who may have cognitive disorders, marked logistical and resource barriers exist for administering neuropsychological assessments on a wide scale. The HABC-M SR cognitive subscale was modeled after the brief selfreport and informant report tools used for patients with mild cognitive impairment and early Alzheimer disease, such as the Cognitive Change Index 14 and the Measurement of Everyday Cognition, 15 and additional work will be needed to refine and validate a self-report or informant-based screening tool for cognitive symptoms in patients with PICS. Reliable cognitive screening tools can help clinicians decide appropriately which patients should be referred for further assessment.
In future studies, investigators will need to examine whether the cognitive subscale of the HABC-M caregiver version is a reliable tool that can provide accurate information on the severity of cognitive symptoms in patients with PICS. Despite the lack of correlation between the results of detailed cognitive testing and scores on a cognitive subscale, the subscale still has some relative value, because CCRC patients did report more cognitive symptoms than did primary care patients.
Strengths and Limitations
The major strength of our study is that we have shown that the HABC-M-SR is an easy-to-use, standardized clinical tool and has potential as a screening tool for rapidly assessing the wide range of symptoms experienced by patients with PICS. Many other investigators [16] [17] [18] [19] [20] have used a wide range of tools to measure psychological symptoms, cognitive performance, and physical functioning. These tools can be time intensive, may require additional training for health care professionals to administer, and are often used in research involving subspecialty care. The HABC-M SR requires little to no training for health care professionals to administer, can be completed within 5 minutes, and can be administered in a wide range of health care settings (eg, primary care and subspecialty outpatient care). The HABC-M SR can also be repeated for longitudinal follow-up of PICS symptoms. Although the number of ICU survivor clinics is rapidly growing, access to this subspecialty care remains quite limited. Developing a tool to rapidly screen ICU survivors for PICS symptoms in other settings (most notably, primary care) can increase the likelihood that ICU survivors are referred to the appropriate subspecialty care that they need.
Subscale
Our study has some limitations. First, the HABC-M SR can be administered only to patients with normal cognition, mild cognitive impairment, or early-stage dementia. Additional studies will be needed to determine whether the caregiver version of the HABC-M is a valid measure of PICS symptoms in patients with moderate to severe dementia. Patients with HABC-M SR scores that indicate no evidence of PICS are less likely to have symptoms suggestive of PICS, but clinicians should always interpret the results of the HABC-M SR in the context of a patient's history and the results of a physical examination. Second, the HABC-M SR was administered in a subspecialty ICU survivor clinic. ICU survivor clinics are more common in Europe, but still fairly rare in the United States, a situation that means many ICU survivors rely on primary care physicians for follow-up after discharge from the hospital. Although additional studies are needed to validate use of the HABC-M SR for screening in larger populations and for longitudinal follow-up, clinicians may find the HABC-M SR helpful in screening for symptoms in ICU survivors and in follow-up.
Although the HABC-M SR has been used in primary care in older patients with possible mild cognitive impairment, early-stage dementia, or late-life depression, the instrument has not been used in primary care to screen younger ICU survivors who may have undetected cognitive, mental health, or functional symptoms that could suggest a diagnosis of PICS. Future studies are needed to determine whether primary care practitioners can accurately administer the HABC-M SR for ICU survivors and then make the appropriate diagnosis and referral for management of PICS on the basis of the results of the HABC-M SR.
The HABC-M SR is a clinical tool that can be administered via multiple means (face-to-face, over the telephone, and via the internet). Future studies are needed to validate whether alternative methods of administration of the HABC-M SR will yield results similar to those of face-to-face administration. Other limitations include the lack of a direct correlation between the HABC-M SR functional subscale and the physical impairments in PICS and selection bias in terms of patients who participated in our study.
Conclusion
As the number of ICU survivors increases, PICS is becoming a major public health issue. Care after discharge from the ICU for these survivors is fragmented. 21 Despite the increase in ICU survivor clinics, most ICU survivors will continue to receive their care from primary care providers. 21, 22 Therefore, health care professionals in all disciplines and specialties need clinical assessment tools for PICS that can be used in a wide range of outpatient settings. The use of such tools allows health care professionals to recognize which patients are experiencing the symptoms of PICS and then refer the patients to critical care or another relevant subspecialty for the management of PICS. These assessment tools need to be short and easy to use for health care professionals with little to no expertise in PICS. The HABC-M SR is such a tool, and future studies are needed to examine potential barriers to the adoption of HABC-M SR in outpatient settings for the diagnosis of PICS.
